Skip to main content
. 2019 Aug 9;10:1870. doi: 10.3389/fimmu.2019.01870

Figure 9.

Figure 9

Graphical summary: the metabolic reprogramming during macrophage polarization induced by M-CSF (M2) and reinforced by IL-10 (M2c) leads to P2Y11 receptor upregulation. Metabolic reprogramming involves activation of a signaling axis comprising AMP-activated kinase (AMPK), nicotinamide phosphoribosyltransferase (NAMPT), and NAD+. NAMPT is the rate-limiting enzyme of the NAD+ salvage pathway, which converts nicotinamide (NAM) into nicotinamide mononucleotide (NMN). NAD+ acts as macrophage metabolite that drives P2Y11 receptor expression, possibly via the NAD+-dependent deactylase SIRT1.